Login
$MLAB
$134.09 -$4.92 (3.54%) Live

$MLAB 8-K SEC Filings

Filed On Filing
09 Nov 2026 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, November 9, 2026 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of critical quality control solutions and life sciences tools, today announced results ...

13 Oct 2026 8-K: Costs Associated with Exit or Disposal Activities; Regulation FD Disclosure

Mesa Laboratories Announces Restructuring and Savings Plan to Reduce Annualized Costs by Approximately $9.3 Million and Reinvest Approximately $4.3 Million in Profitable Growth

08 Sep 2026 8-K: Submission of Matters to a Vote of Security Holders

On September 8, 2026, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,595,869 shares of Mesa’s common stock were entitled to vote, of which 4,872,692 shares were represented in person or by proxy ...

10 Aug 2026 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, August 10, 2026 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or the “Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results fo...

30 Jul 2026 8-K: Amendments to or Waivers of the Code of Ethics

It is the policy of Mesa Laboratories, Inc. and its subsidiaries (the “Company”, “Mesa”, “we”, “us” or “our”) to (i) require the highest standards of business ethics and integrity on the part of all employees and members of its board of ...

15 Jun 2026 8-K: Departure/Election of Directors or Officers; Compensation

This Executive Employment Agreement (the “Agreement”) is entered into and effective on [●] (the “Effective Date”) by and between Mesa Laboratories, Inc. (the “Company”) and [●] (“Executive”).

27 May 2026 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, May 27, 2026 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for i...

23 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation

This CEO Retention and Transition Agreement (this “Agreement”) is entered into by and between Gary M. Owens (“Executive”) and Mesa Laboratories, Inc. (“Company”). Capitalized terms not defined herein shall have the meanings assigned to s...

09 Mar 2026 8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure

This Executive Employment Agreement (the “Agreement”) is entered into and effective on March 3, 2026 (the “Effective Date”) by and between Mesa Laboratories, Inc. (the “Company”) and Siddhartha Kadia (“Executive”).

03 Feb 2026 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, February 3, 2026 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results f...

06 Nov 2025 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, November 6, 2025 – Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa” or “the Company”), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results f...

25 Aug 2025 8-K: Submission of Matters to a Vote of Security Holders

On August 22, 2025, the Company held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,501,454 shares of Mesa’s common stock were entitled to vote, of which 5,203,377 shares were represented in person or by proxy at...

18 Aug 2025 8-K: Creation of a Direct Financial Obligation

Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that it has executed on its previously-announced financial strategy, repaying $97.5 million aggregate principal of the Company’s 1.375% Convert...

05 Aug 2025 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, August 5, 2025 – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its first fiscal quarter ...

06 Jun 2025 8-K: Changes in Registrant's Certifying Accountant

We have read the statements made by Mesa Laboratories, Inc., included under Item 4.01 of its Current Report on Form 8-K dated June 3, 2025 to be filed with the Securities and Exchange Commission. We agree with the statements concerning o...

28 May 2025 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, May 28, 2025 – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its fourth fiscal quarter (...

04 Feb 2025 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, February 4, 2025 – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its third fiscal quarte...

07 Nov 2024 8-K: Results of Operations and Financial Condition

Lakewood, Colorado, November 7, 2024 – Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced results for its second fiscal quart...

11 Sep 2024 8-K: Changes in Registrant's Certifying Accountant

On September 6, 2024, the Audit Committee of the Board of Directors (the “Audit Committee”) of Mesa Laboratories, Inc. (the “Company”) approved the engagement of Moss Adams LLP (“Moss Adams”) as the Company’s independent registered publi...

30 Aug 2024 8-K: Submission of Matters to a Vote of Security Holders

On August 30, 2024, Mesa Laboratories, Inc. (“Mesa” or the “Company”) held its annual meeting of shareholders (the “Annual Meeting”). Holders of 5,409,163 shares of Mesa’s common stock were entitled to vote, of which 5,096,365 shares wer...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support